INNOHEP 4 500 IU anti-Xa/0.45 ml, solution for injection in a pre-filled syringe 10 syringes of 0.45 ml
Active ingredients: Tinzaparin sodium
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 syringes of 0.45 mlsous-cutanée;voie extracorporelle autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- INNOHEP 4 500 UI anti-Xa/0,45 ml, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée;voie extracorporelle autre
- Presentation description
- 10 seringue(s) préremplie(s) en verre de 0,45 ml
- Marketing authorisation holder
- LABORATOIRES LEO
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Apr 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63108338CIP73421713CIP133400934217135Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TINZAPARINE SODIQUEsolution | 4 500 Ul Anti-Xa · 0,45 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.